GloPID-R is a unique international network of major research funding organizations.
Together, we facilitate a rapid and effective response to infectious disease outbreaks.
Our Work
Our aim is to invest in research capacity and capabilities to support the rapid initiation of scientific research in case of an outbreak.
Clinical Trial
Networks
Hear from the experts on topics such as social science, data sharing, capacity building, and EARL barriers.
Read more32 members
Since its creation in 2013, GloPID-R has steadily increased its membership. Today, it consists of 32 members worldwide. The World Health Organization, the Coalition for Epidemic Preparedness Innovations (CEPI) and the European & Developing Countries Clinical Trials Partnership (EDCTP) are also actively engaged in the network.
All membersLatest news
All newsLiving Mapping Review: New iteration brings crucial insights for future COVID-19 research funding as we move to a post-pandemic world
23/03/2022Researchers and funders around the world rely on the COVID-19 Research Project Tracker and associated Living Mapping Review (LMR) to...
Read moreUpcoming webinar: Response to COVID-19 vaccine in patients with a hematological condition and primary immunodeficiencies
07/03/2022The second webinar in the ZonMw series ‘Response to COVID-19 vaccine in patients with a hematological condition and primary immunodeficiencies’...
Read moreGloPID-R and UK DHSC organise funders’ roundtable to strengthen the clinical trials ecosystem
11/02/2022Funders play a critical role in clinical trials, representing a major force in improving trial coordination during global health emergencies....
Read moreResources
GloPID-R publishes funding opportunities related to infectious diseases and shares its expertise through its publications and webinars.
All resources